MEFLOQUINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mefloquine Hydrochloride, and when can generic versions of Mefloquine Hydrochloride launch?
Mefloquine Hydrochloride is a drug marketed by Barr, Hikma, Hikma Intl Pharms, Sandoz, and Us Army Walter Reed. and is included in five NDAs.
The generic ingredient in MEFLOQUINE HYDROCHLORIDE is mefloquine hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mefloquine Hydrochloride
A generic version of MEFLOQUINE HYDROCHLORIDE was approved as mefloquine hydrochloride by BARR on December 29th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEFLOQUINE HYDROCHLORIDE?
- What are the global sales for MEFLOQUINE HYDROCHLORIDE?
- What is Average Wholesale Price for MEFLOQUINE HYDROCHLORIDE?
Summary for MEFLOQUINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 145 |
| Clinical Trials: | 77 |
| Patent Applications: | 1,434 |
| DailyMed Link: | MEFLOQUINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MEFLOQUINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Prodia Diacro Laboratories P.T. | N/A |
| National Research and Innovation Agency of Indonesia | N/A |
| Universitas Padjadjaran | N/A |
Pharmacology for MEFLOQUINE HYDROCHLORIDE
| Drug Class | Antimalarial |
Medical Subject Heading (MeSH) Categories for MEFLOQUINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MEFLOQUINE HYDROCHLORIDE
US Patents and Regulatory Information for MEFLOQUINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | MEFLOQUINE HYDROCHLORIDE | mefloquine hydrochloride | TABLET;ORAL | 076392-001 | Dec 29, 2003 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | MEFLOQUINE HYDROCHLORIDE | mefloquine hydrochloride | TABLET;ORAL | 076175-001 | Feb 20, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | MEFLOQUINE HYDROCHLORIDE | mefloquine hydrochloride | TABLET;ORAL | 076523-001 | Oct 1, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
